ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 207 filers reported holding ARIAD PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 2.16 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $291,000 | -9.3% | 23,354 | -0.3% | 0.00% | -33.3% |
Q3 2016 | $321,000 | +85.5% | 23,429 | 0.0% | 0.00% | +200.0% |
Q2 2016 | $173,000 | -6.0% | 23,429 | -18.5% | 0.00% | -50.0% |
Q1 2016 | $184,000 | +2.2% | 28,732 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $180,000 | -8.2% | 28,732 | -14.4% | 0.00% | 0.0% |
Q3 2015 | $196,000 | -21.9% | 33,582 | +10.5% | 0.00% | 0.0% |
Q2 2015 | $251,000 | -18.2% | 30,379 | -18.4% | 0.00% | -33.3% |
Q1 2015 | $307,000 | +91.9% | 37,229 | +59.7% | 0.00% | +50.0% |
Q4 2014 | $160,000 | -18.4% | 23,319 | -35.8% | 0.00% | 0.0% |
Q3 2014 | $196,000 | -55.6% | 36,345 | -47.6% | 0.00% | -60.0% |
Q2 2014 | $441,000 | +10.5% | 69,295 | +40.0% | 0.01% | -16.7% |
Q1 2014 | $399,000 | +221.8% | 49,492 | +171.5% | 0.01% | +200.0% |
Q4 2013 | $124,000 | -54.1% | 18,230 | +24.3% | 0.00% | -50.0% |
Q3 2013 | $270,000 | +5.1% | 14,670 | -0.3% | 0.00% | -20.0% |
Q2 2013 | $257,000 | – | 14,711 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 12,850,000 | $80,313,000 | 15.61% |
Opaleye Management Inc. | 1,310,000 | $8,188,000 | 3.42% |
Camber Capital Management LP | 5,405,235 | $33,783,000 | 2.18% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 471,516 | $2,947,000 | 1.22% |
HighVista Strategies LLC | 807,100 | $5,044,000 | 0.94% |
JS Capital Management LLC | 630,000 | $3,938,000 | 0.94% |
1492 Capital Management LLC | 202,500 | $1,266,000 | 0.92% |
Palo Alto Investors LP | 2,257,217 | $14,108,000 | 0.78% |
Geduld E E | 185,100 | $1,157,000 | 0.72% |
Elk Creek Partners, LLC | 1,592,527 | $9,953,000 | 0.71% |